vialroom

#cagrilintide 2026-04-10

Friday31 messages5 participantstimes are UTC
Highlights from this day
  • cold_chain_cmdr — i titrated over twice as many weeks as i did on semaglutide and that was right for me, i have it written down somewhere 14:09
  • back_from_away — two Janoshik results on the same WXT lot came back 99.2 and 99.4, closer than i expected 14:16
  • bolus_bo — quick one weekly for me, same day every week, no reason beyond habit 15:27
  • appetite_back — i was sceptical about monotherapy and after 3 months im still sceptical, just less so nobody should copy my schedule, im describing it because people asked what a… 16:29
  • cold_chain_cmdr — slightly off topic but 30 in 0.5ml gives 2mg/ml which is what i use, purely because the units come out round, not advice obviously 16:59
BB

the slower titration in here is community habit as much as anything, the trials had their own schedule

BB

i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something

titrating dead slow

BF

CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it

CC

i titrated over twice as many weeks as i did on semaglutide and that was right for me, i have it written down somewhere

👍2👀2⚠️2
BF

two Janoshik results on the same WXT lot came back 99.2 and 99.4, closer than i expected

🧪3
AB

monotherapy question, did appetite move for you without a GLP-1 alongside

CC

genuine question dropped the GLP-1 and stayed on this alone for 14 months, appetite held but weight barely moved

CC

i keep the two on separate days so if something goes wrong i have a chance of knowing which

BB

quick one weekly for me, same day every week, no reason beyond habit

Cited study
Efficacy and Safety of Cagrilintide in Adults with Overweight or Obesity — Phase 2
The Lancet · 2021
Cagrilintide monotherapy, dose ranging. The combination trials came later.
BB

the fullness effect hasnt faded over 2 months, unlike my semaglutide appetite curve, your mileage will differ

AB

unrelated but changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing

how many weeks before you noticed anything on monotherapy

thats the phase 3 one

16🤝1🔥13

amylin not glp-1

AB

you cannot tell which of the two is doing what in a combination and i stopped pretending i could

combination for me

💀7🎉3🤝1

i was sceptical about monotherapy and after 3 months im still sceptical, just less so
nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

👍14
CC

lost 68lb over 26 months on the combination and i genuinely cannot apportion it

[edited]
CC

slightly off topic but 30 in 0.5ml gives 2mg/ml which is what i use, purely because the units come out round, not advice obviously

👀7

how do people separate which of the two is doing what in a combination

[edited]

unrelated but its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake, we shall see

CC

REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work

slightly off topic but monotherapy did work for me, just slower and smaller than i expected